VEEVA SYS INC shareholders Q3 2023

VEEVA SYS INC's ticker is VEEV and the CUSIP is 922475108. A total of 805 filers reported holding VEEVA SYS INC in Q3 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

VEEVA SYS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DF DENT & CO INC 780,753$158,844,1982.33%
Washington Harbour Partners LP 4,750$966,3882.25%
William Allan Corp 13,334$2,712,8022.15%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 44,560$9,065,7321.92%
Chicago Capital, LLC 194,753$39,622,5021.85%
Seaport Global Advisors, LLC 2,924$594,8881.78%
Champlain Investment Partners, LLC 1,256,377$255,609,9011.66%
Durable Capital Partners LP 889,698$181,009,0581.65%
Thomasville National Bank 74,544$15,165,9771.49%
LYELL WEALTH MANAGEMENT, LP 52,596$10,700,6561.44%
Capital Investment Services of America, Inc. 58,357$11,872,7321.38%
PEREGRINE CAPITAL MANAGEMENT LLC 226,305$46,041,7521.37%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 260,512$53,001,1661.36%
BRANDYWINE MANAGERS, LLC 3,919$797,3211.34%
BRIGHT ROCK CAPITAL MANAGEMENT, LLC 27,000$5,493,1501.34%
RIVERBRIDGE PARTNERS LLC 427,930$87,062,3701.26%
Paragon Advisors, LLC 14,675$2,9851.23%
FRONTIER CAPITAL MANAGEMENT CO LLC 538,386$109,534,6321.20%
Stevard, LLC 5,845$1,189,1651.20%
Goodman Advisory Group, LLC 15,801$3,214,7181.20%
About VEEVA SYS INC

Veeva Systems Inc. is a cloud-based software company that provides solutions for the life sciences industry. The company's software is used by pharmaceutical and biotech companies to manage their sales, marketing, and clinical operations. Veeva's software is designed to help these companies improve their efficiency, compliance, and customer engagement.

Veeva's software suite includes products for customer relationship management, content management, data management, and clinical operations. The company's products are built on a single cloud platform, which allows for seamless integration and data sharing across different departments and functions.

Veeva has been growing rapidly in recent years, with revenue increasing by over 25% in the last fiscal year. The company has a strong customer base, with over 900 customers worldwide, including many of the world's largest pharmaceutical companies.

One of the key factors driving Veeva's success is its focus on the life sciences industry. By specializing in this industry, Veeva has been able to develop software that meets the unique needs and regulatory requirements of pharmaceutical and biotech companies. This has helped the company to differentiate itself from other cloud software providers and build a strong reputation in the industry.

Overall, Veeva Systems Inc. is a promising company with a strong track record of growth and a solid customer base. As the life sciences industry continues to evolve and become more reliant on technology, Veeva is well-positioned to continue its success and help its customers navigate the changing landscape.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists VEEVA SYS INC's shareholders in Q3 2023. To view VEEVA SYS INC's shareholder history, click here.